About Allocyte pharmaceuticals ag

About company

- AlloCyte Pharmaceuticals AG (AlloCyte) is a privately held Swiss company founded in November 2011. - AlloCyte develops innovative small molecule drugs for severe immune-mediated diseases. - AlloCyte targets one of the most powerful families of drug targets, integrins, via a novel pharmacological mechanism. - AlloCyte’s activities are financed by private investors and public funds including the Swiss Commission for Technology and Innovation (CTI).